로딩 중…
지수 로딩 중…
Generate Biomedicines, Inc.
GENB· NASDAQ· Financials· Diversified Financials
$14.49+4.47%
2026-06-18
Price Chart
Generate Biomedicines, Inc.
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.86B |
| Revenue | $32M |
| Net Income | $-203M |
| Total Assets | $330M |
| Net Assets | $-616M |
| Value | |
| P/S | 58.24x |
| FCF Yield | -10.99% |
| Profitability | |
| ROA | -61.53% |
| Op. Margin | -737.04% |
| Revenue Growth | 55.89% |
| Financial Health | |
| Total Debt | $69M |
| FCF | $-204M |
| Cash | $122M |
| Current Ratio | 2.85x |
| Performance | |
| 1M Return | 16.67% |
| From 52W High | -13.49% |
| 1Y MDD | -26.20% |
| Trading | |
| Volume | 1,700,567 shares |
| Trading Value | $24M |